Article Listing - Samaritan also to market Amphocil in Ireland

NIGERIAN HEALTH SPENDING FOR 1992

6 April 1992

The federal government of Nigeria has announced a total figure for health care spending in 1992 of 192 million naira,...

ARES-SERONO GAINS RIGHTS TO CUROSURF

6 April 1992

Swiss pharmaceutical group Ares-Serono has acquired exclusive marketing rights in most European territories for a natural pulmonary surfactant product, Curosurf,...

CHIROS ACQUIRES ENZYMATIX' CHIRAL DIV

6 April 1992

A new UK company, Chiros Ltd, was formed last month to purchase the assets and business of the Chiral division...

APPOINTMENTS AT AKZO

6 April 1992

Akzo NV of the Netherlands has appointed Lodewijk van Wachem and Abraham Cohen as members of its supervisory board.

AUSTRALIAN PMA: MEG MIDDLETON

6 April 1992

Meg Middleton has been appointed public affairs manager for the Australian Pharmaceu-tical Manufacturers Associa-tion, in succession to Wendy Edwards.

FURTHER FALLS FOR DEPRENYL?

6 April 1992

Shares of the Canadian biopharmaceutical company Deprenyl Re-search have recently lost value and could well fall further, according to local...

COMPANY NEWS FROM CHINA

6 April 1992

The Shanghai Medicines and Health Products Import and Export Corporation of China exported products worth $150 million in 1991, reports...

AUSTRALIAN DRUG PROMOTION STUDY

6 April 1992

In Australia, a parliamentary report from the House of Representatives concludes that there is no evidence that hospitality provided...

SANDOZ 1991 EARNINGS JUMP 15%

6 April 1992

Swiss pharmaceutical major Sandoz reported a 15% rise in net profit to 1.11 billion Swiss frances ($732.0 million) for 1991,...

BETA BLOCKERS AND DEPRESSION

6 April 1992

Commonly prescribed beta blockers used to treat conditions such as hypertension, angina and migraine do not cause depression, according to...

Showing 94531-94540 of 95367 articles